AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

SubscribeContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

11 May
AHFS Drug Information logo
AHFS May 2021 Update

This update contains 12 new monographs and 38 revised monographs.

New monographs: Smallpox Vaccine Live; Fenfluramine; Smallpox and Monkeypox Vaccine Live; Ebola Zaire Vaccine Live; Bamlanivimab and Etesevimab; Tepotinib; Evinacumab-dgnb; Umbralisib; Trilaciclib; COVID-19 Vaccine (Janssen); Casimersen; Ponesimod

Revised monographs: Tapentadol; Bamlanivimab; Casirivimab and Imdevimab; Vibegron; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); Relugolix; Naxitamab-gqgk; HYDROcodone; Tuberculin; HYDROmorphone; Levorphanol; Codeine; Electrolytes; Meperidine; Thioridazine; OxyMORphone; OxyCODONE; Morphine; Methadone; Naloxone; Mafenide; Opium; Pentazocine; Urea; Sodium Thiosulfate; Carbol-Fuchsin; FentaNYL; Irrigating Solutions; Butorphanol; Nalbuphine; Thyroid Agents General Statement; Cathartics and Laxatives General Statement; Metoclopramide; Naltrexone; Buprenorphine; Interferon Alfa; TraMADol

13 Apr
AHFS Drug Information logo
AHFS April 2021 Update

This update contains 8 new monographs and 4 revised monographs.

New monographs: Remimazolam; Margetuximab-Cmkb; Cabotegravir Sodium; Cabotegravir And Rilpivirine; Voclosporin; Abametapir; Collagenase Clostridium Histolyticum-Aaes; Vericiguat

Revised monographs: Abatacept; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); Immune Globulin

09 Mar
AHFS Drug Information logo
AHFS March 2021 Update

This update contains 9 new monographs and 13 revised monographs.

New monographs: Setmelanotide; Tirbanibulin; Lonafarnib; Ansuvimab-zykl; Vibegron; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); Relugolix; Naxitamab-gqgk

Revised monographs: Triptorelin; HMG-CoA Reductase Inhibitors General Statement; Goserelin; Adalimumab; Mycophenolate; Crizotinib; Ceritinib; Alectinib; Tamoxifen; Leuprolide; Anastrozole; Letrozole; Exemestane

09 Feb
AHFS Drug Information logo
AHFS February 2021 Update

This update contains 3 new monographs and 7 revised monographs.

New monographs: Lumasiran Sodium; Berotralstat; Oliceridine Fumarate

Revised monographs: Montelukast; Brinzolamide; Brimonidine; Phentermine and Topiramate; Timolol; Betaxolol; Dorzolamide

12 Jan
AHFS Drug Information logo
AHFS January 2021 Update

This update contains 3 new monographs, 53 revised monographs and 33 new MedWatch alerts.

New monographs: Atoltivimab, Maftivimab, and Odesivimab-ebgn; Bamlanivimab; Casirivimab and Imdevimab

Revised monographs: Rivastigmine; Meloxicam; Galantamine; Travoprost; Flurbiprofen; Pregabalin; CloBAZam; Ibrutinib; Netarsudil Mesylate; Ivosidenib; Stiripentol; Solriamfetol; Pitolisant; Enfortumab Vedotin-ejfv; Fam-Trastuzumab Deruxtecan-nxki; Fenoprofen; Indomethacin; Mefenamic Acid; Naproxen; Tolmetin; Sulindac; DiazePAM; Oxazepam; Flurazepam; Clorazepate; LORazepam; ChlordiazePOXIDE; Ibuprofen; ClonazePAM; Meclofenamate; Valproate/Divalproex; Aspirin; Anticonvulsants General Statement; Carbonic Anhydrase Inhibitors General Statement; ALPRAZolam; Temazepam; Triazolam; Diflunisal; Piroxicam; Levobunolol; Ketoprofen; Diclofenac; Ketorolac; Quazepam; CloZAPine; Estazolam; Etodolac; Nabumetone; Oxaprozin; Gabapentin; Topiramate; Donepezil; Celecoxib

New MedWatch alerts on the following monographs: Meloxicam; Flurbiprofen; Fenoprofen; Indomethacin; Mefenamic Acid; Naproxen; Tolmetin; Sulindac; Ibuprofen; Meclofenamate; Aspirin; Diflunisal; Piroxicam; Ketoprofen; Diclofenac; Ketorolac; Etodolac; Nabumetone; Oxaprozin; Celecoxib; Clobazam; Diazepam; Oxazepam; Flurazepam; Clorazepate; Lorazepam; Chlordiazepoxide; Clonazepam; Alprazolam; Temazepam; Triazolam; Quazepam; Estazolam

08 Dec
AHFS Drug Information logo
AHFS December 2020 Update

This update contains 1 new monograph, 43 revised monographs and 1 discontinued monograph.

New monograph: Nifurtimox

Revised monographs: Mifepristone; Bimatoprost; Alemtuzumab (Antineoplastic); Memantine; Tolvaptan; Tafluprost; Dolutegravir; Idelalisib; Panobinostat; Parathyroid Hormone; Alemtuzumab (MS); Blinatumomab; Flibanserin; Latanoprostene bunod; Semaglutide; Pegvaliase-pqpz; Duvelisib; Inotersen; Revefenacin; Ravulizumab-cwvz; Ketamine; Esketamine; Brexanolone; Pexidartinib; Enfortumab Vedotin-ejfv; Tazemetostat; Remdesivir; Satralizumab-mwge; Levorphanol; Codeine; Meperidine; Oxymorphone; Morphine; Loxapine; Pentazocine; Hydrocodone; Butorphanol; Cathartics and Laxatives General Statement; Insulin Human; Tramadol; Latanoprost; Olanzapine; Thalidomide

Discontinued monograph: Delavirdine

View more View all content updates